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We report a case of urothelial carcinoma (UC) in a 69-year-old man that occurred after renal
transplantation. He had started receiving hemodialysis therapy in 2004 due to diabetic nephropathy and
underwent living related renal transplantation from his brother in 2005. He was referred to our hospital in
May 2009 with asymptomatic microscopic hematuria. Cystoscopy findings revealed multiple bladder
tumors, and transurethral resection of bladder tumor (TUR-BT) followed by intravesical instillation of
pirarubicin was performed. Histopathological findings revealed UC (G1＞G2, pTa). Cytology findings
after the operation did not become negative; urine specimen from the native right ureter was positive, and
abdominal computed tomography (CT) demonstrated a right pelvic tumor. In January 2010, a
laparoscopic right nephroureterectomy was performed and pathological examination findings revealed UC in
the right pelvis (G3＞G2, INFβ, pT3). In March 2010, recurrence of the bladder tumor was demonstrated
as carcinoma in situ (CIS) of the bladder and left native ureter. In June 2010, a radical cystectomy with left
nephroureterectomy and ileal conduit diversion were performed. One week after that operation, laboratory
results revealed abnormal hepatic function and CT showed multiple liver metastases. The patient died in
August 2010, 2 months after surgery.
(Hinyokika Kiyo 59 : 117-120, 2013)












既往歴 : 高血圧症， 2型糖尿病．
現病歴 : 2004年 5月，糖尿病性腎不全により血液透
析を導入．2005年 2月，弟をドナーとした ABO 適合
生体腎移植術を施行．以後血清クレアチニン値は




嗜好歴 : 喫煙は100本/日×40年で 7年前から禁煙
していた．機会飲酒程度．
入院時現症 : 174.8 cm，79.6 kg，129/62 mmHg，
54 bpm，35.3°C，右下腹部に手術瘢痕を認めた．
血液検査 : WBC 5,400/mm3，RBC 354×104/mm3，
Hb 11.3g/dl，PLT 13.7×104/mm3，Cr 1.58 mg/dl，
BUN 37 mg/dl，CRP 0.03 mg/dl．
尿検査 : 糖−，蛋白−，潜血 2＋，白血球 1＋
尿細胞診 : Urothelial carcinoma class V を前医で認め
た．
画像検査 : MRI 検査では右側壁を中心とした多発
性膀胱腫瘍を認めた (Fig. 1）．筋層断裂に関しては明
らかではなかった．
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Fig. 1. MRI revealed multiple tumor of the bladder.
入院後経過 : 2009年 6月経尿道的膀胱腫瘍切除術
（以下 TURBT) を施行した．術後 pirarubicin 20 mg の
膀胱内注入を行った．病理所見は UC，G1＞G1
(PUNLMP) ＞G2，pTa であった．多発性膀胱腫瘍で
あったため，2009年 7月 2nd TURBT を施行した．後













Fig. 3. Clinical course of this patient.
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た．手術時間は 7時間48分，出血量は 190 ml であっ
た．病理結果は，urothelial carcinoma of the right renal
pelvis，UC＞CIS，G3＞G2，INFβ，pT3 と urothelial

















2,500 ml であった．病理結果は urothelial carcinoma in
situ of the urinary bladder，CIS，G2，pTis と urothelial
carcinoma in situ of the left ureter，CIS，G2，pTis で
あった．術後 1週間ほどで AST 54 IU/l，ALT 57 IU/
l，ALP 357 IU/l と肝機能異常を認めたため，腹部造
影 CT 検査を施行したところ，肝臓に多発転移性腫瘍
を認めた．尿路上皮癌の肝転移と診断し，積極的加療
























































Table 1. Summary of reported cases of urothelial
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